hydroxyproline has been researched along with mycophenolic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gakis, D; Imvrios, G; Papanikolaou, V; Sikas, N; Takoudas, D | 1 |
Aihara, M; Hattori, K; Hirano, T; Iwata, F; Muraguchi, M; Nakano, Y; Nishibayashi, S; Takiguchi, Y; Uehara, K; Yamada, Y | 1 |
Eikyu, Y; Kinugasa, F; Kozuki, Y; Kubo, K; Morokata, T; Nakanishi, T; Noto, T; Seki, N; Umeno, H | 1 |
Dagli, AF; Gundogdu, B; Isik, A; Koca, SS; Ozgen, M; Ustundag, B | 1 |
4 other study(ies) available for hydroxyproline and mycophenolic acid
Article | Year |
---|---|
Mycophenolate mofetil impairs the integrity of colonic anastomosis.
Topics: Anastomosis, Surgical; Animals; Colon; Fibroblasts; Hydroxyproline; Immunohistochemistry; Immunosuppressive Agents; Inflammation; Macrophages; Male; Mycophenolic Acid; Pressure; Rats; Rats, Wistar; Rupture; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Wound Healing | 2006 |
Functional and structural changes in end-stage kidney disease due to glomerulonephritis induced by the recombinant alpha3(IV)NC1 domain.
Topics: Actins; Animals; Autoantigens; Collagen Type I; Collagen Type IV; Creatinine; Disease Models, Animal; Female; Gene Expression; Glomerulonephritis; Hydroxyproline; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Function Tests; Lisinopril; Mycophenolic Acid; Prednisolone; Rats; Rats, Inbred WKY; Recombinant Proteins; Transforming Growth Factor beta1 | 2010 |
Effect of the inosine 5'-monophosphate dehydrogenase inhibitor BMS-566419 on renal fibrosis in unilateral ureteral obstruction in rats.
Topics: Acridines; Animals; Chemokine CCL2; Chronic Disease; Collagen; Fibrosis; Hydroxyproline; IMP Dehydrogenase; Kidney Cortex; Kidney Diseases; Male; Mycophenolic Acid; Piperazines; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Ureteral Obstruction | 2010 |
Mycophenolate mofetil and daclizumab targeting T lymphocytes in bleomycin-induced experimental scleroderma.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal, Humanized; Bleomycin; Cytokines; Daclizumab; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Hydroxyproline; Immunoglobulin G; Immunohistochemistry; Immunosuppressive Agents; Injections, Subcutaneous; Mice; Mice, Inbred BALB C; Mycophenolic Acid; Scleroderma, Localized; Skin | 2012 |